← Evidence map

TrialHeadache2021

Timing and durability of response to erenumab in patients with chronic migraine.

Stewart J Tepper et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

4 papers cite it

2021
2022
2023
this paperpooled ittrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 34363708